Ali Montazeri

TL;DR: The findings suggest that the Iranian version of the Short Form Health Survey (SF-36) is a reliable and valid measure of health related quality of life among the general population.

TL;DR: Quality of life data provided scientific evidence for clinical decision-making and conveyed helpful information concerning breast cancer patients' experiences during the course of the disease diagnosis, treatment, disease-free survival time, and recurrences; otherwise finding patient-centered solutions for evidence-based selection of optimal treatments, psychosocial interventions, patient-physician communications, allocation of resources, and indicating research priorities were impossible.

TL;DR: This preliminary validation study of the Iranian version of the HADS proved that it is an acceptable, a reliable and valid measure of psychological distress among cancer patients.

TL;DR: It is indicated that the epidemiological aspects of breast cancer in Iran are relatively well‐studied and shortcomings in study of its clinical aspects are evident and need to be a central part of upcoming investigations.

TL;DR: Global quality of life, functioning domains and symptom scores - such as appetite loss, fatigue and pain - were the most important indicators, individually or in combination, for predicting survival times in cancer patients after adjusting for one or more demographic and known clinical prognostic factors.